S.I. No. 542/2008 - Irish Medicines Board (Fees) Regulations 2008

View PDF
S.I. No. 542 of 2008
IRISH MEDICINES BOARD (FEES) REGULATIONS 2008
Notice of the making of this Statutory Instrument was published in
“Iris Oifigiúil” of 19th December, 2008.
I, MARY HARNEY, Minister for Health and Children, in exercise of the powers conferred on me by sections 13 and 32 of the Irish Medicines Board Act 1995 (No. 29 of 1995), as adapted by the Health (Alteration of Name of Department and Title of Minister) Order 1997, ( S.I. No. 308 of 1997 ) and of all other powers enabling me in that behalf, hereby make the following Regulations:
1. These Regulations may be cited as the Irish Medicines Board (Fees) Regulations 2008.
2. These Regulations shall come into force on the 1st day of January 2009.
3. In these Regulations—
“Board” means the Irish Medicines Board;
“manufacturing licence” means a licence granted pursuant to the Medical Preparations (Licensing of Manufacture) Regulations 1993 to 1996;
“product authorisation” means an authorisation granted pursuant to the Medical Preparations (Licensing and Sale) Regulations 1998 ( S.I. No. 142 of 1998 );
“wholesale licence” means a licence granted pursuant to the Medical Preparations (Wholesale Licences) Regulations 1993 to 1996.
4. These Regulations shall apply to the fees that may be charged by the Board, in pursuit of its statutory duties, in relation to applications for the grant or renewal of manufacturing licences, wholesale licences and product authorisations in respect of medicinal products for human use.
5. Subject to Regulation 6 hereof, there shall be paid to the Board in respect of each and every matter set out in column 1 of the schedule hereto the fee as set out in column 2 of the said schedule.
6. The Board may, in circumstances where it considers it appropriate to do so, waive, remit or refund, either in whole or in part, any fee that would otherwise be payable to it under Regulation 5 hereof.
7. The Irish Medicines Board (Fees) Regulations 2007 ( S.I. No. 866 of 2007 ) are hereby revoked.
SCHEDULE
COLUMN 1 COLUMN 2
Fees for National Applications for Product Authorisations
€
National application — complex dossier, new active substance
15,211
Each additional form (same time)
5,090
Each additional strength (same time)
656
Additional drug master file submitted with any of the above
3,251
National application — reduced complex
11,329
Each additional form (same time)
5,090
Each additional strength (same time)
656
Additional drug master file submitted with any of the above
3,251
National application — reduced dossier standard
7,658
Each additional form (same time)
5,090
Each additional strength (same time)
656
Additional drug master file submitted with any of the above
3,251
Subsequent extension applications — first additional form
7,658
Each additional form (same time)
5,090
First additional strength (existing form)
2,756
Each additional strength (same time)
656
Additional drug master file submitted with any of the above
3,251
Fees for Applications for Product Authorisations using European Mutual Recognition procedure
Mutual recognition incoming — complex dossier, new active substance
10,647
Each additional form (same time)
3,660
Each additional strength (same time)
656
Outgoing mutual recognition/decentralised supplement
10,962
Decentralised Outgoing/Incoming
15,211
Each additional form (same time)
5,090
Each additional strength (same time)
656
Additional supplement DCP outgoing greater than 10 countries
5,000
Mutual recognition incoming — reduced complex
8,077
Each additional form (same time)
3,251
Each additional strength (same time)
656
Outgoing mutual recognition / decentralised supplement
10,962
Decentralised Outgoing/Incoming
11,329
Each additional form (same time)
5,090
Each additional strength (same time)
656
Additional supplement DCP outgoing greater than 10 countries
5,000
Mutual recognition incoming — reduced dossier standard
5,350
Each additional form (same time)
2,859
Each additional strength (same time)
656
Outgoing mutual recognition / decentralised supplement
7,126
Decentralised Outgoing/Incoming
7,658
Each additional form (same time)
5,090
Each additional strength (same time)
656
Additional supplement DCP outgoing greater than 10 countries
5,000
Subsequent extension applications
— mutual recognition incoming (first additional form)
5,350
— mutual recognition incoming (first additional strength)
1,929
— mutual recognition incoming (subsequent additional strength)
656
Outgoing mutual recognition/decentralised supplement (additional form)
2,859
Outgoing mutual recognition/decentralised supplement (additional strength)
656
Decentralised Outgoing / Incoming First Additional Form
7,658
Each additional form (same time)
5,090
First additional strength (existing form)
2,756
Each additional strength (same time)
656
Additional supplement DCP outgoing greater than 10 countries
5,000
Change of address for Product Authorisation holder: 1 to 20
Product Authorisations
119
Change of address for Product Authorisation holder: more than
20 Product Authorisations
591
Fees for Parallel Product Authorisations
Application fee — per country at the same time or by variation
1,662
Each additional strength per country
495
Each additional form per country
495
Dual pack registration of parallel imports
564
Each additional strength or form
283
Change of Ownership
525
Fees for Variations to Product Authorisations that are nationally licensed
Type IA variation
365
Type IA variation — reduced rate
184
Type IB variation
495
Type IB variation — reduced rate
248
Type II complex variation
3,251
Type II standard variation
633
Type II standard variation — reduced rate
316
Notifications made under Article 61 (3) of Directive 2001 / 83 / EC
495
Notifications made under Article 61 (3) of Directive 2001 / 83 / EC— reduced rate
248
Bulk variation to multiple changes to the SPC (per product range)
8,000
Bulk variation for multiple changes to the same document
6,000
Introduction of standard statements from PHV working party — 1 to 5licences
1,500
Introduction of standard statements from PHV working party — 6 to 10 licences
3,000
Introduction of standard statements from PHV working party — 11 to 20 licences
6,000
Introduction of standard statements from PHV working party — 21 to 40 licences
12,000
Introduction of standard statements from PHV working party — 41 to 100 licences
20,000
Introduction of standard statements from PHV working party — 101 and above
30,000
Fees for Variations to Product Authorisations licensed under European Mutual Recognition procedure
Type IA variation — outgoing mutual recognition / decentralised supplement
365
Type IA variation — mutual recognition incoming
315
Type IA variation — mutual recognition incoming — reduced rate
184
Type IB variation outgoing mutual recognition / decentralised supplement
365
Type IB variation — mutual recognition incoming
422
Type IB variation — mutual recognition incoming — reduced rate
218
Type II complex variation — outgoing mutual recognition / decentralised supplement
656
Type II complex variation — mutual recognition incoming
2,246
Type II standard variation — mutual recognition incoming
422
Type II standard variation — mutual recognition incoming — reduced rate
218
Type II standard variation — outgoing mutual recognition / decentralised supplement
422
Notifications made under Article 61 (3) of Directive 2001 / 83 / EC
495
Notifications made under Article 61 (3) of Directive 2001 / 83 / EC— reduced rate
248
Fees for the granting of a Product Authorisation on transfer to another company
Change of ownership — related company — per form
1,123
Change of ownership — related company — per strength
321
Change of ownership — non-related company — per form
1,645
Change of ownership — non-related company — per strength
321
Other fees relating to the granting of Product Authorisations
Service item
612
Fees for Wholesale Licences
Application fee
555
Annual fee — large site
2,771
Annual fee — medium site
1,576
Annual fee — minor site
555
Variation to licence — administrative
219
Variation to licence — technical
603
Fees for Manufacturing Licences
Application fee
1,853
Annual fee — major site (more than 250 employees)
16,669
Annual fee — large site (150 — 250 employees)
11,112
Annual fee — medium site (50 — 149 employees)
7,409
Annual fee — small site (less than 50 employees)
3,703
Variation to licence — administrative
274
Variation to licence — technical
768
Fees for Blood and Tissue Establishments
Application fee
1,853
Annual fee — major site (more than 250 employees)
16,669
Annual fee — large site (150 — 250 employees)
11,112
Annual fee — medium site (50 — 149 employees)
7,409
Annual fee — small site (less than 50 employees)
3,703
Variation to licence — administrative
274
Variation to licence — technical
768
Fees for Laboratory Approvals
Application fee
555
Annual fee — minor site
555
Variation to licence — administrative
219
Variation to licence — technical
603
Fees for the granting of a Manufacturing Licence or a Wholesale Licence on transfer to another company
Manufacture — related companies
1,107
Manufacture — unrelated companies
1,853
Wholesale — related companies
365
Wholesale — unrelated companies
555
Fees for Notifications of Exempt Medicinal Products
Per notification
2
Cap on total notifications
10,000
Fees for Medical Devices
Certificates of free sale
Certificates of free sale issued within 2 days (4 certs per request)
147
Certificates of free sale issued within 1 day (4 certs per request)
277
Additional certificates (available at the time of the initial request)
23
Registration of Devices
Registration of In-vitro Diagnostic medical device
153
First registration of a general medical device
153
Re-registration of items currently on the market
153
Changes to registration thereafter
153
Electronic registration
131
Annual Verification Fee — up to 5 employees
153
Annual Verification Fee — between 6-20 employees
384
Annual Verification Fee — between 21-100 employees
768
Annual Verification Fee — Over 100 employees
1,645
Clinical Investigations
Clinical Investigations — active implantable medical devices
3,837
Clinical Investigations — Class III and class IIb medical devices
3,837
Clinical Investigations — Class IIa and class I medical device
1,645
Clinical Investigations — Technical amendment to a previously
approved clinical investigation
1,129
Clinical Investigations — Administrative amendment to a previously
approved clinical investigation
219
Audits / Inspections
Audits/ Inspections (including Notified Body) per day
1,489
Audits/Inspections (including Notified Body) per hour
234
Classifications
Classification of a product (1 product per request)
250
Classification of additional products (available at the time of the initial request)
200
Appeal of a classification decision
250
Designation Fee for a Notified Body
Designation Fee
3,672
Extension to the scope (per extension)
1,836
Medicinal Product/Medical Device — Drug Consultation fees
New active substance
41,960
Established active in new therapeutic area
33,568
Established active and therapeutic area
29,372
Variations — Minor
839
Variations — Major
3,776
GIVEN under my Official Seal ,
15 December 2008
MARY HARNEY.
Minister for Health and Children.
EXPLANATORY NOTE
(This note is not part of the Instrument and does not purport to be a legal instrument.)
The purpose of these Regulations is to provide for the revision of fees payable to the Irish Medicines Board pursuant to Section 13 of the Irish Medicines Board Act 1995 .

View PDF